Lyell Immunopharma (LYEL) Other Non Operating Income (2020 - 2025)
Historic Other Non Operating Income for Lyell Immunopharma (LYEL) over the last 6 years, with Q3 2025 value amounting to -$4.9 million.
- Lyell Immunopharma's Other Non Operating Income fell 1120000.0% to -$4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 194903.85%. This contributed to the annual value of $4.7 million for FY2024, which is 15427.95% up from last year.
- Per Lyell Immunopharma's latest filing, its Other Non Operating Income stood at -$4.9 million for Q3 2025, which was down 1120000.0% from $1.2 million recorded in Q2 2025.
- In the past 5 years, Lyell Immunopharma's Other Non Operating Income registered a high of $4.3 million during Q4 2024, and its lowest value of -$4.9 million during Q3 2025.
- Its 5-year average for Other Non Operating Income is $310368.4, with a median of -$14000.0 in 2022.
- Per our database at Business Quant, Lyell Immunopharma's Other Non Operating Income surged by 676818.18% in 2022 and then crashed by 1120000.0% in 2025.
- Over the past 5 years, Lyell Immunopharma's Other Non Operating Income (Quarter) stood at -$44000.0 in 2021, then soared by 6768.18% to $2.9 million in 2022, then tumbled by 117.25% to -$506000.0 in 2023, then surged by 948.22% to $4.3 million in 2024, then tumbled by 213.21% to -$4.9 million in 2025.
- Its Other Non Operating Income stands at -$4.9 million for Q3 2025, versus $1.2 million for Q2 2025 and $1.3 million for Q1 2025.